Back

Two-dimensional speckle-tracking echocardiography in tafamidis-treated patients with transthyretin amyloid cardiomyopathy: a glimmer of hope for viable therapy monitoring?

29 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Rene Rettl

Medical University of Vienna, Vienna (Austria)

7 More presentations in this session

Presentation thumbnail
Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis
Doctor A. Ioannou (Greater London, GB)
Abstract Slides
Presentation thumbnail
Transthyretin amyloid cardiomyopathy: a 2-year single-centre experience
Doctor B. Rocha (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms
Doctor G. Neculae (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Detection of arrhythmias in patients with cardiac amyloidosis using implantable ECG recorders.
Professor M. Taborsky (Usti Nad Labem, CZ)
Abstract Slides
Presentation thumbnail
Unveiling cardiac amyloidosis, its characteristics and outcomes among patients with mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair
Doctor C. Nitsche (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Cardiac amyloidosis

The Event

Event poster

ESC Congress 2022

29 August 2022 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources